Completed PHASE1 INTERVENTIONAL 2-arm NCT01051336

Safety and Tolerability Study of the Taris Placebo System

Phase I Safety and Tolerability Study of the Taris Placebo System (A Novel Bladder Drug Delivery Platform)

Sponsor: TARIS Biomedical, Inc.

Conditions Healthy

Interventions Sham Procedure TARIS Placebo

Updated 5 times since 2017 Last updated: Jan 15, 2010 Started: Oct 31, 2009 Primary completion: Nov 30, 2009 Completion: Nov 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by TARIS Biomedical, Inc. and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Feb 2017 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TARIS Biomedical, Inc.

Data source: TARIS Biomedical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Phoenix, United States